Cooper Companies | COO - Current Liabilities



Cooper Companies reported $1.01B in Current Liabilities for its fiscal quarter ending in July of 2025.


Current Liabilities Change Date
Abbott USD 13.44B 435M Jun/2025
Align Technology USD 2B 4.54M Jun/2025
AtriCure USD 68.84M 7.62M Jun/2025
Avanos Medical USD 134.6M 2.6M Jun/2025
Bausch Health Companies USD 4.98B 719M Jun/2025
Baxter International USD 3.48B 3.03B Mar/2025
Bayer EUR 29.78B 1.82B Jun/2025
Becton, Dickinson and Co. USD 8.16B 469M Jun/2025
Boston Scientific USD 5.06B 1.34B Mar/2025
Cooper Companies USD 1.01B 2.4M Jul/2025
Dentsply International USD 1.17B 627M Jun/2025
Dexcom USD 3.31B 271.6M Jun/2025
Edwards Lifesciences USD 1.39B 110.4M Mar/2025
Globus Medical USD 424.66M 39.96M Jun/2025
Haemonetics USD 531.41M 46.71M Jun/2025
Hologic USD 962.5M 27.2M Jun/2025
Insulet USD 1.01B 489.7M Jun/2025
Integra LifeSciences USD 929.81M 11.35M Jun/2025
Intuitive Surgical USD 2.21B 197.4M Jun/2025
J&J USD 56.9B 6.58B Mar/2025
Medtronic USD 12.88B 1.04B Apr/2025
Merit Medical Systems USD 225.57M 28.75M Jun/2025
Novartis USD 31.71B 3.02B Jun/2025
ResMed USD 1.02B 78.6M Jun/2025
STAAR Surgical USD 59.23M 9.13M Jun/2025
Steris USD 926.6M 95.57M Jun/2025
Stryker USD 7.29B 641M Jun/2025
Tandem Diabetes Care USD 251.69M 36.48M Jun/2025
Teleflex USD 716.15M 40.24M Jun/2025
Zimmer Biomet Holdings USD 2.7B 404.6M Jun/2025